• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰分离的粪肠球菌环丙沙星耐药临床菌株的新型gyrase突变及特征分析

Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland.

作者信息

Piekarska Katarzyna, Gierczyński Rafał, Ławrynowicz-Paciorek Maja, Kochman Maria, Jagielski Marek

机构信息

National Institute of Public Health, National Institute of Hygiene, Department of Bacteriology, Warsaw, Poland.

出版信息

Pol J Microbiol. 2008;57(2):121-4.

PMID:18646399
Abstract

The activity of ciprofloxacin, sparfloxacin and moxifloxacin was determined for 205 Enterococcus faecalis isolates from patients of five hospitals (Warsaw, Poland; collected from 2000 to 2002). Ciprofloxacin resistant and intermediate isolates were numerous (53.7%). Among them, highly resistant (MIC > or = 16 mg/l) isolates predominated (98%). Isolates resistant to ciprofloxacin were also resistant to sparfloxacin and moxifloxacin. The parC and gyrA QRDRs (quinolone-resistance-determining region) of 11 isolates with ciprofloxacin MICs from 1 to 256 mg/l were analysed by DNA sequencing. In ParC one kind of amino acid substitution (of Ser-85 to Ile) in 9 E. faecalis strains with MICs from 16 to 256 mg/l was observed. In GyrA Ser-84 was changed to one of four different amino acids: Arg, Ile, Cys or Tyr, however no association between the amino acid type and MIC value was found. The last two substitutions have not been reported to date for E. faecalis. Moreover, our results may suggest that mutations within parC and gyrA are associated with development of a high-level of ciprofloxacin resistance.

摘要

对来自五家医院(波兰华沙;2000年至2002年收集)患者的205株粪肠球菌分离株测定了环丙沙星、司帕沙星和莫西沙星的活性。对环丙沙星耐药和中介的分离株数量众多(53.7%)。其中,高度耐药(MIC≥16mg/L)的分离株占主导(98%)。对环丙沙星耐药的分离株对司帕沙星和莫西沙星也耐药。通过DNA测序分析了11株环丙沙星MIC为1至256mg/L的分离株的parC和gyrA喹诺酮耐药决定区(QRDR)。在ParC中,观察到9株MIC为16至256mg/L的粪肠球菌菌株中有一类氨基酸取代(Ser-85变为Ile)。在GyrA中,Ser-84变为四种不同氨基酸之一:Arg、Ile、Cys或Tyr,然而未发现氨基酸类型与MIC值之间存在关联。后两种取代迄今为止尚未在粪肠球菌中报道。此外,我们的结果可能表明parC和gyrA内的突变与高水平环丙沙星耐药性的发展有关。

相似文献

1
Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland.波兰分离的粪肠球菌环丙沙星耐药临床菌株的新型gyrase突变及特征分析
Pol J Microbiol. 2008;57(2):121-4.
2
[Genetical conditioning of fluoroquinolone resistance mechanisms of clinical enterococcus faecalis strains. II. The mutations present in the qrdrs of gyrA, gyrB, parC and parE genes].
Med Dosw Mikrobiol. 2007;59(4):329-41.
3
In vitro development of resistance to DX-619 and other quinolones in enterococci.肠球菌对DX - 619及其他喹诺酮类药物的体外耐药性发展
J Antimicrob Chemother. 2006 Dec;58(6):1268-73. doi: 10.1093/jac/dkl421. Epub 2006 Oct 24.
4
In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.莫西沙星对耐氟喹诺酮类需氧革兰氏阴性杆菌和粪肠球菌菌株的体外活性。
J Antimicrob Chemother. 1999 May;43 Suppl B:19-23. doi: 10.1093/jac/43.suppl_2.19.
5
Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.波兰华沙一家三级医院分离的氟喹诺酮类耐药临床肠杆菌科中存在质粒介导的喹诺酮类耐药决定因素以及 gyrA 和 parC 基因突变的共存现象。
Int J Antimicrob Agents. 2015 Mar;45(3):238-43. doi: 10.1016/j.ijantimicag.2014.09.019. Epub 2014 Nov 13.
6
In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.司帕沙星对肺炎链球菌临床菌株的体外活性,这些菌株在gyrase A和拓扑异构酶IV的喹诺酮耐药决定区(QRDRs)中有特定的氨基酸替代。
J Antimicrob Chemother. 2006 Dec;58(6):1279-82. doi: 10.1093/jac/dkl427. Epub 2006 Oct 20.
7
Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.鲍曼不动杆菌中与喹诺酮耐药相关的GyrA基因Ser83Leu和ParC基因Ser80Leu替换。
Microb Drug Resist. 2015 Jun;21(3):345-51. doi: 10.1089/mdr.2014.0057. Epub 2014 Dec 16.
8
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.化脓性链球菌emm6型中高水平氟喹诺酮耐药性的出现以及环丙沙星、左氧氟沙星和莫西沙星的体外耐药性选择。
J Antimicrob Chemother. 2009 May;63(5):886-94. doi: 10.1093/jac/dkp057. Epub 2009 Mar 11.
9
Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.印度引起肠热症的耐环丙沙星肠炎沙门氏菌伤寒血清型和甲型副伤寒血清型的分子特征分析
J Antimicrob Chemother. 2006 Dec;58(6):1139-44. doi: 10.1093/jac/dkl391. Epub 2006 Oct 28.
10
The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.gyrA和parC突变在来自伊朗的耐氟喹诺酮铜绿假单胞菌分离株中的作用。
Braz J Microbiol. 2016 Oct-Dec;47(4):925-930. doi: 10.1016/j.bjm.2016.07.016. Epub 2016 Jul 26.

引用本文的文献

1
Co-Incidence of Type II Topoisomerase Mutations and Efflux Expression in High Fluoroquinolone Resistant Isolated from Urinary Tract Infections.从尿路感染分离出的高氟喹诺酮耐药菌株中II型拓扑异构酶突变与外排表达的共现情况
Infect Drug Resist. 2020 Feb 18;13:553-559. doi: 10.2147/IDR.S237299. eCollection 2020.
2
Frequency of ace, epa and elrA Genes in Clinical and Environmental Strains of Enterococcus faecalis.临床和环境粪肠球菌中 ace、epa 和 elrA 基因的频率。
Indian J Microbiol. 2012 Dec;52(4):612-6. doi: 10.1007/s12088-012-0285-8. Epub 2012 Jun 22.